RSH 13.0% 2.6¢ respiri limited

I think their marketing plan is to start with the pharmacies,...

  1. 49 Posts.
    lightbulb Created with Sketch. 26
    I think their marketing plan is to start with the pharmacies, where they will be sold, including the focus on educating pharmacists- for which take up so far has been very promising. It has also focused on the peak asthma association- again, where asthmatics will get information from.

    I think GPs have been a part of the different studies - I also know GP access is a crowded space. But as the company has not yet explicitly provided information on how GPS will be informed of Wheezo, I am at a loss as to what information this forum can provide you on this?

    Personally, I am much happier with the company’s focus on pharmacies than on GPS - as a starting point - as previous boards have talked about GPs but not delivered.

    I am happy to wait for further advice from the company on how/when GPs are engaged as part of the marketing strategy.



 
watchlist Created with Sketch. Add RSH (ASX) to my watchlist
(20min delay)
Last
2.6¢
Change
0.003(13.0%)
Mkt cap ! $29.81M
Open High Low Value Volume
2.2¢ 2.6¢ 2.1¢ $17.69K 789.3K

Buyers (Bids)

No. Vol. Price($)
2 99463 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 199999 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RSH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.